undamentalytics Newsletter
Sign in

Pennant Group, Inc. revenue

Pennant Group, Inc.'s revenue was $948m in fiscal 2025, up 36.3% on the year before. Since fiscal 2017 ($251m) it has grown at a compound 18.1% a year. Over the last twelve months it was $1.10bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2512863393914404735456959481,102
Growth on the year before—+14.0%+18.3%+15.5%+12.5%+7.6%+15.1%+27.6%+36.3%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Home Health and Hospice Services $731M 77.3% ▲ 41.9%
Senior Living Services $215M 22.7% ▲ 22.3%

From Pennant Group, Inc.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Pennant Group, Inc. $1.10bn 37.9% 30.0%
Guardant Health, Inc. $1.18bn 42.7% 32.4%
Innovage Holding Corp. $990m 15.9% 12.9%
Corvel Corp $984m 7.1% 10.3%
Progyny, Inc. $1.31bn 5.5% 11.0%
Healthequity, Inc. $1.36bn 7.3% 13.2%

Compare with peers

Head to head: GH vs PNTGINNV vs PNTGCRVL vs PNTG

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Pennant Group, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pennant Group, Inc.